Meeting
2021 Gastrointestinal Cancers Symposium
Duloxetine (DL) in treatment of oxaliplatin-induced peripheral neuropathy (PN).
Authors
Jeffrey Chi
Northwell Health Cancer Institute, Lake Success, NY
Jeffrey Chi , Fatima Fayyaz , Su Yun Chung , Jyothi Jose , Anna W. Komorowski , Maura Dillon , Patnita Shepherd , Kenneth D. Gold , Wasif M. Saif
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Esophageal and Gastric Cancer
Track
Esophageal and Gastric Cancer
Sub Track
Symptoms, Toxicities, and Whole-Person Care
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 195)
DOI
10.1200/JCO.2021.39.3_suppl.195
Abstract #
195
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Preventives for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients.
First Author: Robert Brooks Hines
Poster
2023 ASCO Annual Meeting
A novel genetic marker of fluoropyrimidine-induced cardiovascular toxicity.
First Author: Claire Palles
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase II study of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 followed by gastrectomy with D2 plus para-aortic nodal dissection for gastric cancer with extensive lymph node metastasis: JCOG1704.
First Author: Takaki Yoshikawa
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A meta-analysis of bevacizumab’s cardiovascular risks in patients treated for colorectal cancer.
First Author: Akshit Chitkara